How to Buy Neogenomics Stock

Neogenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments.

Neogenomics stock last closed at $14.86, up 1.36% from the previous day, and has decreased 6.25% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.16 percentage points. Neogenomics stock is currently +22.56% from its 52-week low of $12.13, and -22.26% from its 52-week high of $19.12.

As of Jan 24, 2025, there are 128.36M NEO shares outstanding. The market value of NEO is $1.91B. In the last 24 hours, 429,153 NEO shares were traded.

How to Buy Neogenomics Stock

Wondering how to invest in Neogenomics stock? Here's how.

  1. Choose where to buy Neogenomics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Neogenomics stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your brokerage account: Pick your payment method and add your info.
  4. Analyze Neogenomics stock: The Neogenomics ticker symbol is NEO. Is Neogenomics stock a good investment? Should you buy shares of NEO? How do NEO's underlying business fundamentals look? Do top analysts think Neogenomics is a good buy? Why has NEO's stock price moved recently? (Hint: Our stock market research website can help you understand if NEO is a good stock to buy).
  5. Make your NEO trade: Decide if you will purchase NEO shares at the current market price or use a limit order to buy NEO shares at a given price.
  6. Keep an eye on your NEO investment: Create a watchlist to monitor your investment in Neogenomics shares.

Step 1: Choose where to buy Neogenomics stock

You will need a brokerage account in order to access the NASDAQ market and buy NEO shares.

A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world financial markets: From Tech to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in NEO stock today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create a new brokerage account.
  1. Send your info by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've finished signing up on the best app for stock investing, you can securely and quickly fund your account:

Watch the video below for more details transferring funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Neogenomics stock

After you have figured out the best place to buy Neogenomics stock, it's crucial to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.

Neogenomics Numbers

NEO Price
$14.86
1w %
4.57%
1y %
-6.25%
5y %
-53.99%
P/E
-24.36x
P/B
2.1x
P/S
2.93x
PEG
N/A
Revenue
$644.12M
Earnings
-$77.73M
Fore. Rev. Growth
14.65%
Fore. Earn. Growth
N/A
Market Cap
$1.91B
Next Earnings
Feb 18, 2025
Next Dividend
N/A

Neogenomics Due Diligence Checks

WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on NEO's stock page.

Is NEO stock undervalued or overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge NEO's true value.

Using relative valuations metrics:

  • NEO could be undervalued based on its P/B ratio of 2.1x, relative to Diagnostics & Research industry P/B ratio of 4.23x

You can access additional valuation analysis on NEO's stock here.

NEO Financial Health Overview

Positive Health Checks:

  • NEO has cash burn of 21512000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the NEO balance sheet.
  • NEO profit margin has gone up from -16.8% to -12.1% in the past year.
  • NEO has $387.81M in cash and short term investments. This is sufficient to cover its annual cash burn of $21.51M.
  • There are more short-term assets than short-term liabilities on the NEO balance sheet.

Negative Health Checks:

  • Total NEO debt is higher than 5 years ago, relative to shareholder equity.
  • NEO has a relatively high debt to equity ratio of 0.81.

Is Neogenomics stock a Buy, Hold, or Sell, according to analysts?

Out of 5 Wall Street analysts who give recommendations on NEO, the consensus analyst rating on Neogenomics is a Strong Buy

It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Neogenomics stock forecast page.

NEO Technical Indicators

SMA10
14.23
SMA20
15.75
SMA50
16.45
SMA100
15.56
SMA200
15.15
MACD
-0.66
MACD Signal
-0.55
MACD Histogram
-0.11
RSI
44.85
Stochastic %K
36.46
Stochastic %D
33.58
StochRSI %K
40.24
StochRSI %D
36.62

NEO Growth Numbers

Last year, NEO revenue was $644.12M. Over the past 5 year, NEO's revenue has gone up by 11.22% per year. This was faster than the Diagnostics & Research industry average of 9.64%.

Dig into NEO's earnings and revenue performance here.

Who is buying/selling NEO?

Over the last 12 months, insiders at NEO have sold more shares than they have bought.

Alicia C. Olivo, General Counsel of NEO, was the latest NEO insider to sell. They sold $79,472.48 worth of NEO shares on Nov 15, 2024.

Research more about who owns NEO shares here.

Can I rely on NEO as an income stream?

No, Neogenomics doesn't provide an income stream by paying out dividends.

Get analysis from other traders

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Make your NEO trade

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.

Hit the Open button and eToro will place the order.

If you need additional info about investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep an eye on your NEO investment

Now that you own some shares in NEO, you'll want to keep up with your company.

Create a watchlist to track the most important metrics related to your NEO stock.

NEO Feed

How to Buy Stock in Neogenomics

To reiterate, here are the 6 steps for buying Neogenomics stock:

  1. Choose where to buy Neogenomics stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Neogenomics stock
  5. Make your NEO trade
  6. Keep an eye on your NEO investment

If you require a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to watch your investment in Neogenomics, get started below.

NASDAQ: NEO
$14.86+0.20 (+1.36%)
Updated Jan 24, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: NEO
$14.86+0.20 (+1.36%)
Updated Jan 24, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Neogenomics share?

As of Jan 24, 2025, it costs $14.86 to buy one share of Neogenomics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.471 shares of NEO.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Neogenomics stock?

According to 5 Wall Street analysts who monitor Neogenomics, their consensus recommendation is to buy Neogenomics stock.

What is the best way to buy Neogenomics stock?

One way to place an order for Neogenomics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.